Second Sight Medical Files For IPO

Sylmar-based Second Sight Medical, a medical devices maker developing treatments for outer retinal degenerations, such as retinitis pigmentosa, filed for an IPO this week, saying that it is looking to raise up to $45M in an IPO on the Nasdaq Capital Market. The IPO is being underwritten by MDB Capital Group. The company said it expects to offer its stock at $9.00 per share, trading under the symbol EYES. Second Sight Medical is backed by medical devices mogul Alfred E. Mann.